Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Analytical Scientist
  • Explore

    Explore

    • Latest
    • News & Research
    • Trends & Challenges
    • Keynote Interviews
    • Opinion & Personal Narratives
    • Product Profiles
    • App Notes
    • The Product Book

    Featured Topics

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy

    Issues

    • Latest Issue
    • Archive
  • Topics

    Techniques & Tools

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy
    • Microscopy
    • Sensors
    • Data and AI

    • View All Topics

    Applications & Fields

    • Clinical
    • Environmental
    • Food, Beverage & Agriculture
    • Pharma and Biopharma
    • Omics
    • Forensics
  • People & Profiles

    People & Profiles

    • Power List
    • Voices in the Community
    • Sitting Down With
    • Authors & Contributors
  • Business & Education

    Business & Education

    • Innovation
    • Business & Entrepreneurship
    • Career Pathways
  • Events
    • Live Events
    • Webinars
  • Multimedia
    • Video
    • Content Hubs
Subscribe
Subscribe

False

The Analytical Scientist / Issues / 2026 / March / Proteomic Profiling Defines Vascular Cell States
Omics Proteomics News and Research Translational Science Mass Spectrometry

Proteomic Profiling Defines Vascular Cell States

Label-free LC–MS profiles nearly 5,000 cells, resolving smooth muscle subtypes and disease-associated phenotypes 

03/18/2026 2 min read

Share

A label-free single-cell proteomics workflow may enable more detailed characterization of cell states in complex vascular tissue, where protein-level measurements help resolve disease-associated heterogeneity. 

In the study, researchers at Cedars-Sinai Medical Center applied a liquid chromatography–mass spectrometry–based approach to cells isolated from mouse aortic tissue in a model of Marfan syndrome, profiling nearly 5,000 individual cells and quantifying an average of around 500 proteins per cell. 

To achieve this, the researchers used a direct, label-free workflow using nano-scale liquid chromatography and high-sensitivity mass spectrometry. By avoiding multiplexed labeling strategies, the method reduces ratio compression and improves quantitative accuracy for low-abundance proteins in single cells. 

Clustering of the proteomic data identified major aortic cell types, including smooth muscle cells, endothelial cells, fibroblasts, and immune cells, alongside multiple subpopulations within these groups. Smooth muscle cells – which dominated the dataset – were further divided into seven distinct phenotypes spanning contractile and more modified states. 

Several of these smooth muscle subtypes showed distinct protein signatures and were differentially represented in Marfan tissue. In particular, subsets enriched in the disease model exhibited increased abundance of proteins such as low-density lipoprotein receptor–related protein 1 (LRP1) and protease serine 2 (PRSS2), suggesting shifts toward altered or proliferative phenotypes. 

The analysis also revealed cell-type–specific changes associated with disease. Endothelial cells from Marfan mice showed reduced expression of adhesion proteins alongside increased levels of smooth muscle–associated proteins, consistent with endothelial-to-mesenchymal transition. Spatial proteomics experiments confirmed both the presence and anatomical distribution of key markers identified in the single-cell data. 

Comparison with published single-cell RNA sequencing datasets showed agreement at the level of major cell types, but limited overlap in finer subpopulations such as smooth muscle subtypes. Integrating transcriptomic and proteomic data produced additional clusters, indicating that protein-level measurements capture complementary aspects of cellular state. 

The authors highlight targets including ACE, TPM4, LRP1, and PRSS2 as potential markers of disease-associated cell states, and suggest that multi-omic approaches could help clarify how these phenotypic shifts contribute to aneurysm progression. 

 

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

Recommended

False

Related Content

The Analytical Scientist Innovation Awards 2024: #7
Omics
The Analytical Scientist Innovation Awards 2024: #7

December 2, 2024

4 min read

Frank Steemers, co-founder and CSO of Scale Biosciences, tells us the story of ScalePlex – the 7th ranked innovation on this year’s Awards

The Analytical Scientist Innovation Awards 2024: #4
Omics
The Analytical Scientist Innovation Awards 2024: #4

December 5, 2024

6 min read

Thermo Fisher Scientific’s high-sensitivity mass spec for translational omics research – the Stellar MS – is ranked 4th in our annual Innovation Awards

Let Me See That Brain
Omics
Let Me See That Brain

December 9, 2024

1 min read

TRISCO sets a new standard for 3D RNA imaging, delivering high-resolution and uniform images to offer insights into brain function and anatomy

The Analytical Scientist Innovation Awards 2024
Omics
The Analytical Scientist Innovation Awards 2024

December 11, 2024

10 min read

Meet the products – and the experts – defining analytical innovation in 2024

False

The Analytical Scientist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.